Home Newsfeeds RBC Capital Maintains Outperform on Magna International, Lowers Price Target to $65

RBC Capital Maintains Outperform on Magna International, Lowers Price Target to $65

RBC Capital analyst Joseph Spak maintains Magna International (NYSE:MGA) with a Outperform and lowers the price target from $69 to $65.

byBenzinga Newsdesk

November 7, 2022

1 minute read

RBC Capital analyst Joseph Spak maintains Magna International (NYSE:MGA) with a Outperform and lowers the price target from $69 to $65.

Crypto Influencer’s Impressions Of ‘Soul-Crushing’ Dubai Resembling ‘Live GTA Game’ With Supercars And Models Go Viral

By Khyathi Dalal

April 23, 12:42 PM

Pseudonymous crypto influencer Tim went viral with a post on X (formerly Twitter), detailing his observations about Dubai and the cryptocurrency industry from attending the Token 2049 conference.

BTC

News

Mesoblast Announces Advancements In Phase 3 Trials iIQ2 Activity Report, Registers $1.5M in Royalty Revenue From TEMCELL® HS Inj.5 Sales In Japan

By Benzinga Newsdesk

January 31, 3:10 AM

Mesoblast Chief Executive Silviu Itescu said: "It has been a very busy quarter in which we have made substantial operational progress across our three lead Phase 3 assets. We have generated significant new potency

MESO

HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $21 Price Target

By Benzinga Newsdesk

February 10, 8:53 AM

HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price target.

NVCT

Morgan Stanley Declares $270M Investment Into Bitcoin ETFs In Q1, Leads Institutional Inflow Of ‘Historical Scale’

By Murtuza Merchant

May 16, 11:02 AM

Morgan Stanley (NYSE:MS) has declared a substantial $269.9 million investment in spot Bitcoin (CRYPTO:

BITB

RBC Capital Maintains Outperform on Magna International, Lowers Price Target to $65

Related Posts

Crypto Influencer’s Impressions Of ‘Soul-Crushing’ Dubai Resembling ‘Live GTA Game’ With Supercars And Models Go Viral

Mesoblast Announces Advancements In Phase 3 Trials iIQ2 Activity Report, Registers $1.5M in Royalty Revenue From TEMCELL® HS Inj.5 Sales In Japan

HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $21 Price Target

Morgan Stanley Declares $270M Investment Into Bitcoin ETFs In Q1, Leads Institutional Inflow Of ‘Historical Scale’